Drug Shortage Report for SANDOZ LOSARTAN HCT DS
Report ID | 73179 |
Drug Identification Number | 02313383 |
Brand name | SANDOZ LOSARTAN HCT DS |
Common or Proper name | LOSARTAN HCT DS |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
Strength(s) | 25MG 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | C09DA |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-10-29 |
Estimated end date | 2020-07-24 |
Actual end date | 2020-07-27 |
Shortage status | Resolved |
Updated date | 2020-07-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2020-07-28 | English | Compare |
v16 | 2020-07-27 | French | Compare |
v15 | 2020-07-27 | English | Compare |
v14 | 2020-06-29 | French | Compare |
v13 | 2020-06-29 | English | Compare |
v12 | 2020-06-08 | French | Compare |
v11 | 2020-06-08 | English | Compare |
v10 | 2020-05-11 | French | Compare |
v9 | 2020-05-11 | English | Compare |
v8 | 2020-05-04 | French | Compare |
v7 | 2020-05-04 | English | Compare |
v6 | 2020-04-06 | French | Compare |
v5 | 2020-04-06 | English | Compare |
v4 | 2020-03-30 | French | Compare |
v3 | 2020-03-30 | English | Compare |
v2 | 2019-01-21 | French | Compare |
v1 | 2019-01-21 | English | Compare |
Showing 1 to 17 of 17